e-learning
resources
Milan 2017
Monday, 11.09.2017
Late-breaking studies in pulmonary diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Frequency and characteristics of TB relapses
V. Testov (Fryazino, Moscow Region, Russian Federation)
Source:
International Congress 2017 – Late-breaking studies in pulmonary diseases
Session:
Late-breaking studies in pulmonary diseases
Session type:
Oral Presentation
Number:
2895
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Testov (Fryazino, Moscow Region, Russian Federation). Late Breaking Abstract - Frequency and characteristics of TB relapses. 2895
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Late Breaking Abstract - Treatment with ATYR1923 reduces biomarkers in COVID-19 pneumonia
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021
Late Breaking Abstract - Atypical clinical and radiological presentation of SARS-CoV-2 infection in the elderly.
Source: Virtual Congress 2020 – COVID-19 clinical studies
Year: 2020
Late Breaking Abstract - Clinical and epidemiological characteristics of Co-infection: respiratory tuberculosis and COVID-19.
Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection
Year: 2021
Late Breaking Abstract - Initiation of patient enrollment in treatment with BPaL in Ukraine: first intermediate results
Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease
Year: 2021
Late Breaking Abstract - Therapeutic drug monitoring in a patient with very advanced XDR-TB
Source: Virtual Congress 2021 – Challenges and advances in the diagnosis and clinical management of tuberculosis
Year: 2021
Late Breaking Abstract - Detection of clinical instability by eNose in COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Late Breaking Abstract - Determinants of disease control in patients with severe COPD. The CLAVE Study
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019
Late Breaking Abstract - Patterns of inhaled corticosteroid-formoterol prescriptions in Poland
Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Year: 2019
Late Breaking Abstract - Impact of the SARS-CoV-2 pandemic on incidence and phenotype of tuberculosis in a UK hotspot
Source: Virtual Congress 2021 – Advances in treatment and management of tuberculosis and nontuberculous mycobacterial disease
Year: 2021
Late Breaking Abstract - Asthma control in preschool and subsequent disease remission
Source: International Congress 2019 – Asthma and the world
Year: 2019
Late Breaking Abstract - Relationship between clinical features and mortality in a cohort of COPD patients.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
Late Breaking Abstract - Defining a severe asthma super-responder: findings from a Delphi process
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
Late Breaking Abstract - Variable costs of sepsis in a Greek ICU
Source: Virtual Congress 2021 – Difficult decisions on expected outcomes: availability of hospital resources and improvement of treatment adherence
Year: 2021
Late Breaking Abstract - Recurrent Neural Networks and environmental data for COPD exacerbation prediction
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020
Late Breaking Abstract - Improving adherence to prescribing remdesivir in COVID-19
Source: Virtual Congress 2021 – Respiratory infections
Year: 2021
Late Breaking Abstract - Early follow-up of hospitalised and non-hospitalised patients with Covid-19 in a Swedish setting
Source: Virtual Congress 2021 – Challenges of COVID-19 management at short and long-term
Year: 2021
Late Breaking Abstract - Implications of new PH definition for CTEPD
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Year: 2021
Late Breaking Abstract - Risk factors for chronic cough in 14669 individuals from the general population
Source: International Congress 2017 – Asthma epidemiology among children and adults: from biomarkers to ACOS
Year: 2017
Late Breaking Abstract - Long COVID-19 symptoms including fatigue are more frequent in females independently of COVID-19 treatment
Source: Virtual Congress 2021 – Biological and functional markers of COVID-19
Year: 2021
Late Breaking Abstract - ‘Shielding’: Patient experience of measures to reduce risk of COVID-19 in those with pre-existing respiratory conditions
Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept